| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
Neuronetics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Compan... |
| 10 Nov 2026 |
8-K: Entry into a Material Definitive Agreement
CERTAIN INFORMATIO IDENTIFIED WITH THE MARK “[***]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT IS PRIVATE OR CONFIDENTIAL. |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
MALVERN, PA., November 4, 2026 – Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the Greenbrook network... |
| 17 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
MALVERN, PA., August 11, 2026 – Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook netwo... |
| 20 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
This Separation Agreement (the “Agreement”) is entered into by and between NEURONETICS, INC., a Delaware corporation, and W. ANDREW MACAN (“Executive”) (together, “the Parties”) to set forth their mutual agreement to resolve and discharg... |
| 23 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 29 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Neuronetics, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 28, 2026 (the “Annual Meeting”). A total of 55,950,118 shares of common stock, representing approximately 80.41% of the shares outstanding and eligible to v... |
| 22 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
This Amended and Restated Consulting Agreement (this “Agreement”), dated as of the later of the dates set forth on the signature page hereto (the “Effective Date”), is made by and between Neuronetics, Inc., together with its subsidiaries... |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
MALVERN, PA., May 5, 2026 – Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of pati... |
| 06 Apr 2026 |
8-K: Entry into a Material Definitive Agreement; Costs Associated with Exit or Disposal Activities +2 more
This EXECUTIVE CONSULTING AND RELEASE AGREEMENT (this “Agreement”), dated as of April 1, 2026 (the “Effective Date”), is made by and between Neuronetics, Inc., a Delaware corporation (“Neuronetics”), and the counterparty set forth on the... |
| 17 Mar 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 |
| 02 Mar 2026 |
8-K: Entry into a Material Definitive Agreement
This Amendment No. 2 to the Registration Rights Agreement (the “Amendment”) is made and entered into this 2nd day of March, 2026 by and among Madryn Select Opportunities, LP, a limited partnership existing under the laws of Delaware (“MS... |
| 25 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 10 Feb 2026 |
8-K: Results of Operations and Financial Condition
Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth on an adjusted pro forma basis |
| 22 Jan 2026 |
8-K: Entry into a Material Definitive Agreement
This AMENDMENT NO. 4 TO CREDIT AGREEMENT AND GUARANTY AND SECURITY AGREEMENT (this “Amendment”) is made as of January 15, 2026, by and between NEURONETICS, INC., as the Borrower (the “Borrower”), and PERCEPTIVE CREDIT HOLDINGS IV, LP, in... |
| 06 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 04 Nov 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 |
| 05 Aug 2025 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth |
| 15 Jul 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
On behalf of everyone at Neuronetics, we are delighted at the prospect of you joining the team as Executive Vice President, Chief Financial Officer and Treasurer, reporting to Keith J. Sullivan, CEO and President. We are pleased to offer... |
Loading...